Fate Therapeutics (FATE) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

FATE is expected to report earnings to rise 27.09% to -41 cents per share on October 31

Fate Therapeutics FATE Stock Earnings Reports

Q3'24

Est.

$-0.42

Q2'24

Beat

by $0.13

Q1'24

Beat

by $0.01

Q4'23

Beat

by $0.07

Q3'23

Beat

by $0.10

The last earnings report on August 13 showed earnings per share of -33 cents, beating the estimate of -46 cents. With 776.61K shares outstanding, the current market capitalization sits at 406.54M.

View a ticker or compare two or three

Compare

FATE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For FATE
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for FATE (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12278 Scripps Summit Drive

Phone

+1 858 875-1800

Employees

220

Web

https://www.fatetherapeutics.com